TRAX — FIRST TRACKS BIOTHERAPEUTICS
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 155 SEC-registered investment managers reported holding TRAX (FIRST TRACKS BIOTHERAPEUTICS) in their latest 13F filings, with a combined reported value of $682.85M across 33.99M shares. Ownership is concentrated: the five largest holders account for 35.7% of reported value and the top ten for 53.4%.
Compared with the prior quarter, 155 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of FIRST TRACKS BIOTHERAPEUTICS (TRAX) include BlackRock Inc, Affinity Asset Advisors, LLC, EcoR1 Capital, LLC, ranked by reported 13F value among the 189 institutional holders on this page.
TRAX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 117 | 16.08M | $570.14M | +7.7% |
| Q2 2026 | 155 | 33.99M | $682.85M | — |
Over the 2 quarters shown, institutional share counts decreased 53% in aggregate (Q2 2026 → Q3 2026).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.60M | $92.04M | 0.00% | Add | |
| 2.08M | $73.72M | 3.43% | Add | |
| 1.75M | $61.92M | 0.00% | Reduce | |
| 1.61M | $57.09M | 0.00% | New | |
| 1.49M | $52.84M | 0.00% | Add | |
| 836.73K | $29.66M | 0.00% | Add | |
| 821.92K | $29.13M | 4.62% | Hold | |
| 780.97K | $27.68M | 0.00% | Add | |
| 756.49K | $26.81M | 0.00% | Reduce | |
| 304.38K | $10.79M | 0.00% | Reduce | |
| 290.00K | $10.28M | 0.01% | Hold | |
| 226.96K | $8.04M | 0.15% | New | |
| 217.98K | $7.73M | 0.00% | Add | |
| 217.67K | $7.71M | 0.03% | New | |
| 162.91K | $5.77M | 0.01% | Reduce | |
| 159.38K | $5.65M | 0.00% | Add | |
| 121.63K | $4.31M | 0.01% | Add | |
| 115.48K | $4.09M | 0.01% | Reduce | |
| 96.94K | $3.44M | 0.01% | Reduce | |
| 89.36K | $3.17M | 0.04% | New | |
| 86.99K | $3.08M | 0.00% | Add | |
| 86.17K | $3.05M | 0.01% | Reduce | |
| 69.79K | $2.47M | 0.65% | New | |
| 66.79K | $2.37M | 0.00% | Add | |
| 64.47K | $2.28M | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.17M | $63.87M | 3.28% | New | |
| 2.90M | $58.25M | 1.40% | New | |
| 2.05M | $41.33M | 0.00% | New | |
| 2.03M | $40.88M | 1.97% | New | |
| 1.96M | $39.51M | 0.00% | New | |
| 1.51M | $30.46M | 4.84% | New | |
| 1.45M | $29.21M | 0.00% | New | |
| 1.09M | $21.96M | 0.01% | New | |
| 1.01M | $20.38M | 0.48% | New | |
| 917.18K | $18.45M | 0.06% | New | |
| 821.92K | $16.54M | 3.10% | New | |
| 781.53K | $15.72M | 0.00% | New | |
| 750.00K | $15.09M | 0.80% | New | |
| 729.00K | $14.67M | 0.02% | New | |
| 714.95K | $14.38M | 0.05% | New | |
| 702.09K | $14.13M | 0.00% | New | |
| 702.09K | $14.13M | 0.00% | New | |
| 647.96K | $13.04M | 0.00% | New | |
| 622.72K | $12.53M | 2.77% | New | |
| 603.49K | $12.14M | 1.68% | New | |
| 565.20K | $11.37M | 0.61% | New | |
| 546.99K | $11.01M | 0.00% | New | |
| 487.21K | $9.80M | 0.00% | New | |
| 408.33K | $8.22M | 0.03% | New | |
| 310.89K | $6.26M | 0.00% | New |
New Positions (Q2 2026)
- EcoR1 Capital, LLC 3.17M sh · $63.87M
- TCG Crossover Management, LLC 2.90M sh · $58.25M
- Fidelity Management & Research (FMR) 2.05M sh · $41.33M
- Affinity Asset Advisors, LLC 2.03M sh · $40.88M
- BlackRock Inc 1.96M sh · $39.51M
- Trails Edge Capital Partners, LP 1.51M sh · $30.46M
- VANGUARD CAPITAL MANAGEMENT LLC 1.45M sh · $29.21M
- Jupiter Topco LLC 1.09M sh · $21.96M
- Vestal Point Capital, LP 1.01M sh · $20.38M
- Woodline Partners LP 917.18K sh · $18.45M
- Sanofi 821.92K sh · $16.54M
- Morgan Stanley 781.53K sh · $15.72M
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 |
|---|---|---|
| BlackRock Inc | 2.60M | 1.96M |
| Affinity Asset Advisors, LLC | 2.08M | 2.03M |
| Fidelity Management & Research (FMR) | 1.75M | 2.05M |
| STATE STREET CORP | 1.61M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.49M | 1.45M |
| Geode Capital Management | 836.73K | 702.09K |
| Sanofi | 821.92K | 821.92K |
| Invesco Ltd | 780.97K | 71.01K |
| Morgan Stanley | 756.49K | 781.53K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 304.38K | 546.99K |
| FEDERATED HERMES, INC. | 290.00K | 290.00K |
| KENNEDY CAPITAL MANAGEMENT LLC | 226.96K | — |
| VANGUARD FIDUCIARY TRUST CO | 217.98K | 191.22K |
| LORD, ABBETT & CO. LLC | 217.67K | — |
| Connor, Clark & Lunn Investment Management Ltd. | 162.91K | 164.79K |
| Deutsche Bank AG | 159.38K | 62.12K |
| BNP PARIBAS FINANCIAL MARKETS | 121.63K | 5.16K |
| Rockefeller Capital Management L.P. | 115.48K | 116.94K |
| Ensign Peak Advisors, Inc | 96.94K | 115.98K |
| Verition Fund Management LLC | 89.36K | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold TRAX?
As of 2026-Q2, 155 institutional funds reported holding TRAX (FIRST TRACKS BIOTHERAPEUTICS) in SEC 13F filings, with a combined reported value of $682.85M.
How many shares of TRAX do institutions own?
13F filers reported 33.99M shares of TRAX, worth $682.85M in aggregate at the end of 2026-Q2.
Is institutional ownership of TRAX rising or falling?
No prior-quarter baseline is available for a directional read.
Who are the top institutional holders of TRAX?
The largest 13F holders are BlackRock Inc, Affinity Asset Advisors, LLC, EcoR1 Capital, LLC, Fidelity Management & Research (FMR), TCG Crossover Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of FIRST TRACKS BIOTHERAPEUTICS?
The major shareholders of FIRST TRACKS BIOTHERAPEUTICS (TRAX) by reported 13F value are BlackRock Inc, Affinity Asset Advisors, LLC, EcoR1 Capital, LLC, Fidelity Management & Research (FMR), TCG Crossover Management, LLC, among 189 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.